title: First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis.
authors.affiliation: Department of Rheumatology, Yokosuka City Hospital; and Department of Haematology and Clinical Immunology, Yokohama City University School of Medicine, Japan. daiichinaika2005@yahoo.co.jp.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Asami
authors.affiliation: Department of Nephrology, Yokosuka City Hospital, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ishiguro
authors.affiliation: Department of Haematology and Clinical Immunology, Yokohama City University School of Medicine, Japan.
authors.forename: Atsuhisa
authors.initials: A
authors.lastname: Ueda
authors.affiliation: Department of Haematology and Clinical Immunology, Yokohama City University School of Medicine, Japan.
authors.forename: Hideaki
authors.initials: H
authors.lastname: Nakajima
mesh_terms: D000069594:Abatacept / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008875:Middle Aged
chemical_list: D018501:Antirheumatic Agents; D000069594:Abatacept